Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Stock Quotes and News

Auxilium Pharmaceuticals, Inc. (AUXL) 16.50 0.03

Price Open:	15.25	Day's Range:	0.00000 - 22.43000
Price Close:	15.10	52wk Range:	0.00000 - 29.37
Price Day Change:	0.03	Volume:	650,999
Price % Change:	0.20	Market Cap:	745.3M
Bid:	13.91000	PE Ratio:	9.43
Ask:	16.50000	EPS Diluted:	1.602

Trade AUXL NOW!

The Latest On AUXL

Mid-Afternoon Market Update: Nam Tai Plummets as SINA Rises 4/29/13 3:28pm

Mid-Day Market Update: Auxilium Drops On Weak Sales, Conceptus Surges 4/29/13 12:48pm

Stocks Hitting 52-Week Lows 4/29/13 10:26am

Earnings Scheduled For April 29, 2013 4/29/13 4:13am

A Peek Into The Market Before The Trading Starts 3/25/13 7:26am

Auxilium Pharmaceuticals Announces Positive Top-line Data from Phase IIa Study of XIAFLEX for Frozen Shoulder Syndrome 3/25/13 7:11am

UPDATE: Deutsche Bank Reiterates Buy Rating, Lowers PT on Auxilium Pharmaceuticals on Strong Q4 EPS 2/27/13 11:45am

UPDATE: Bank of America Lowers Auxilium Pharmaceuticals PO to $25 Following 4Q12 Results 2/27/13 10:34am

Earnings Scheduled For February 26, 2013 2/26/13 5:24am

Auxilium Pharmaceuticals Announces Issuance of $350.0M of 1.50% Convertible Senior Notes Due 2018 1/30/13 5:47pm

Cowen and Company Reiterates Outperform Rating on Auxilium Pharmaceuticals 1/7/13 2:07pm

Auxilium Pharmaceuticals Expands Field of Exclusive License for XIAFLEX 1/7/13 8:05am

Press Releases

Auxilium Pharmaceuticals, Inc. To Present At The UBS Global Health Care Conference 5/15/13 Newswire

Auxilium Pharmaceuticals, Inc. To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference 5/10/13 Newswire

Auxilium Pharmaceuticals Completes Acquisition Of Actient Holdings LLC To Create A Leading Urology Franchise With A Diversified Product Portfolio And Strong Growth Profile 4/29/13 Newswire

Auxilium Pharmaceuticals, Inc, Announces First Quarter 2013 Financial Results 4/29/13 Newswire

Auxilium Pharmaceuticals to Announce First Quarter 2013 Results and Conduct Conference Call on Monday, April 29, 2013 4/25/13 Newswire

Auxilium Pharmaceuticals, Inc. Announces Positive Top-line Data from XIAFLEX® (CCH) Frozen Shoulder Syndrome Phase IIa Study 3/25/13 Newswire

Auxilium Pharmaceuticals, Inc. to Present at the Cowen and Company 33rd Annual Healthcare Conference 3/4/13 Newswire

Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013 2/26/13 Newswire

Auxilium Pharmaceuticals, Inc. to Present at the Leerink Swann Global Healthcare Conference 2/12/13 Newswire

Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2012 Results and Conduct Conference Call on Tuesday, February 26, 2013 2/12/13 Newswire

Auxilium Pharmaceuticals, Inc. Announces Issuance of $350.0 Million of 1.50% Convertible Senior Notes Due 2018 1/30/13 Newswire

Auxilium Pharmaceuticals, Inc. and Xstelos Holdings, Inc. File Lawsuit Against Upsher-Smith Laboratories, Inc. for Infringement of Testim® Patents 1/28/13 Newswire

Get the latest AUXL stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Auxilium Pharmaceuticals, Inc. stock price.

Partner Headlines

Wider Loss at Auxilium, Acquires Actient - Analyst Blog 4/30/13

Positive Data on BSTC's Xiaflex - Analyst Blog 4/1/13

Actavis Files ANDA for Endo Product - Analyst Blog 3/5/13

Auxilium Beats on All Fronts - Analyst Blog 3/1/13

Zacks Rank #5 Additions for Tuesday - Tale of the Tape 2/12/13

Data on Auxilium's Xiaflex - Analyst Blog 2/7/13

Repros Delays ZA-301 Study Results - Analyst Blog 1/31/13

AUXL Files Patent Infringement Suit - Analyst Blog 1/31/13

Zacks #5 Rank Additions for Tuesday - Tale of the Tape 1/8/13

Patent Challenge for Auxilium Pharma - Analyst Blog 1/4/13

Standard Review for Auxilium's Drug - Analyst Blog 12/28/12